Erratum to: Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus and comparison of hypoglycemic action of concomitant medications: a subanalysis of the JAMP study.

MLA

Ujihara, Noriko, et al. “Erratum to: Efficacy and Safety of Sitagliptin in Elderly Patients with Type 2 Diabetes Mellitus and Comparison of Hypoglycemic Action of Concomitant Medications: A Subanalysis of the JAMP Study.” Diabetology International, vol. 9, no. 1, Feb. 2018, pp. 66–67. EBSCOhost, https://doi.org/10.1007/s13340-017-0338-7.

APA

Ujihara, N., Sakura, H., Hashimoto, N., Sasamoto, K., Ohashi, H., Hasumi, S., Kasahara, T., Tomonaga, O., Nunome, H., Honda, M., Iwamoto, Y., & for the JAMP Study Investigators. (2018). Erratum to: Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus and comparison of hypoglycemic action of concomitant medications: a subanalysis of the JAMP study. Diabetology International, 9(1), 66–67. https://doi.org/10.1007/s13340-017-0338-7

Chicago

Ujihara, Noriko, Hiroshi Sakura, Naotake Hashimoto, Kazuo Sasamoto, Hiroshi Ohashi, Sumiko Hasumi, Tadasu Kasahara, et al. 2018. “Erratum to: Efficacy and Safety of Sitagliptin in Elderly Patients with Type 2 Diabetes Mellitus and Comparison of Hypoglycemic Action of Concomitant Medications: A Subanalysis of the JAMP Study.” Diabetology International 9 (1): 66–67. doi:10.1007/s13340-017-0338-7.